Suppr超能文献

子痫前期的潜在蛋白质生物标志物

Potential Protein Biomarkers for Preeclampsia.

作者信息

He Andong, Zhou Yixuan, Wei Yiling, Li Ruiman

机构信息

Obstetrics and Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou, CHN.

Obstetrics and Gynecology, The First Affiliate Hospital of Jinan University, Guangzhou, CHN.

出版信息

Cureus. 2020 Jun 30;12(6):e8925. doi: 10.7759/cureus.8925.

Abstract

To date, the etiology of preeclampsia (PE) has not been clarified and the specific treatment is lacking; hence, early prediction and prevention are very important. Thus, a large number of biomarkers that may be associated with PE have been identified based on proteomics to provide a reference for the prediction of PE and for the understanding of the pathological mechanisms of this disease. This article briefly summarizes the application of proteomics in PE and the potential protein biomarkers to provide a reference for other researchers.

摘要

迄今为止,子痫前期(PE)的病因尚未阐明,且缺乏特效治疗方法;因此,早期预测和预防非常重要。基于蛋白质组学,大量可能与PE相关的生物标志物已被鉴定出来,为PE的预测及该疾病病理机制的理解提供参考。本文简要总结蛋白质组学在PE中的应用以及潜在的蛋白质生物标志物,为其他研究人员提供参考。

相似文献

1
Potential Protein Biomarkers for Preeclampsia.
Cureus. 2020 Jun 30;12(6):e8925. doi: 10.7759/cureus.8925.
2
Serum protein profile analysis via label-free quantitation proteomics in patients with early-onset preeclampsia.
J Obstet Gynaecol. 2023 Dec;43(2):2259982. doi: 10.1080/01443615.2023.2259982. Epub 2023 Sep 24.
3
[Identification of proteomic biomarkers of preeclampsia using protein microarray and tandem mass spectrometry].
Postepy Hig Med Dosw (Online). 2015 May 4;69:562-70. doi: 10.5604/17322693.1151286.
5
First trimester serum biomarker discovery study for early onset, preterm onset and preeclampsia at term.
Placenta. 2022 Oct;128:39-48. doi: 10.1016/j.placenta.2022.08.010. Epub 2022 Aug 27.
6
Urine proteomic studies in preeclampsia.
Proteomics Clin Appl. 2015 Jun;9(5-6):501-6. doi: 10.1002/prca.201400092. Epub 2015 Apr 24.
7
Identification of Biomarkers for Preeclampsia Based on Metabolomics.
Clin Epidemiol. 2022 Mar 19;14:337-360. doi: 10.2147/CLEP.S353019. eCollection 2022.
8
Screening of differentially expressed proteins in placentas from patients with late-onset preeclampsia.
Proteomics Clin Appl. 2022 Mar;16(2):e2100053. doi: 10.1002/prca.202100053. Epub 2021 Nov 10.
9
A systematic review on the application of vascular endothelial growth factors in preeclampsia.
Ann Palliat Med. 2021 Aug;10(8):9259-9266. doi: 10.21037/apm-21-2109.
10
ST2 and galectin-3 as novel biomarkers for the prediction of future cardiovascular disease risk in preeclampsia.
J Obstet Gynaecol. 2022 Jul;42(5):1023-1029. doi: 10.1080/01443615.2021.1991293. Epub 2021 Dec 21.

引用本文的文献

1
Novel biomarkers for preeclampsia: Promises and pitfalls.
Curr Opin Obstet Gynecol. 2025 Aug 1;37(4):294-301. doi: 10.1097/GCO.0000000000001047. Epub 2025 Jun 3.
4
Role of CA-125 Level as a Marker in the Management of Severe Pre-Eclampsia.
Healthcare (Basel). 2022 Dec 7;10(12):2474. doi: 10.3390/healthcare10122474.
5
Robust identification of temporal biomarkers in longitudinal omics studies.
Bioinformatics. 2022 Aug 2;38(15):3802-3811. doi: 10.1093/bioinformatics/btac403.
7
COVID-19 and Preeclampsia: Overlapping Features in Pregnancy.
Rambam Maimonides Med J. 2022 Jan 27;13(1):e0007. doi: 10.5041/RMMJ.10464.
8
Integrated Learning: Screening Optimal Biomarkers for Identifying Preeclampsia in Placental mRNA Samples.
Comput Math Methods Med. 2021 Feb 23;2021:6691096. doi: 10.1155/2021/6691096. eCollection 2021.

本文引用的文献

1
The role of hemoglobin degradation pathway in preeclampsia: A systematic review and meta-analysis.
Placenta. 2020 Mar;92:9-16. doi: 10.1016/j.placenta.2020.01.014. Epub 2020 Jan 27.
2
A review of omics approaches to study preeclampsia.
Placenta. 2020 Mar;92:17-27. doi: 10.1016/j.placenta.2020.01.008. Epub 2020 Jan 22.
3
Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia.
Hypertens Pregnancy. 2019 Aug;38(3):193-199. doi: 10.1080/10641955.2019.1640725. Epub 2019 Jul 10.
6
CircRNA-0004904, CircRNA-0001855, and PAPP-A: Potential Novel Biomarkers for the Prediction of Preeclampsia.
Cell Physiol Biochem. 2018;46(6):2576-2586. doi: 10.1159/000489685. Epub 2018 May 7.
8
Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.
Pregnancy Hypertens. 2018 Apr;12:124-128. doi: 10.1016/j.preghy.2018.04.010. Epub 2018 Apr 11.
9
Angiogenic and antiangiogenic factors in preeclampsia.
Pathol Res Pract. 2018 Jan;214(1):7-14. doi: 10.1016/j.prp.2017.10.021. Epub 2017 Oct 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验